Ken Yoshida

2.7k total citations
140 papers, 2.0k citations indexed

About

Ken Yoshida is a scholar working on Pulmonary and Respiratory Medicine, Otorhinolaryngology and Radiation. According to data from OpenAlex, Ken Yoshida has authored 140 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Pulmonary and Respiratory Medicine, 47 papers in Otorhinolaryngology and 45 papers in Radiation. Recurrent topics in Ken Yoshida's work include Head and Neck Cancer Studies (47 papers), Advanced Radiotherapy Techniques (45 papers) and Prostate Cancer Diagnosis and Treatment (31 papers). Ken Yoshida is often cited by papers focused on Head and Neck Cancer Studies (47 papers), Advanced Radiotherapy Techniques (45 papers) and Prostate Cancer Diagnosis and Treatment (31 papers). Ken Yoshida collaborates with scholars based in Japan, United States and Germany. Ken Yoshida's co-authors include Hideya Yamazaki, Thomas A. Stoffregen, Satoaki Nakamura, Yasuo Yoshioka, Yasuo Yoshioka, Takehiro Inoue, Tadayuki Kotsuma, Eiichi Tanaka, Kazuhiko Ogawa and Rei Ogawa and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Ken Yoshida

129 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ken Yoshida Japan	24	744	602	551	497	335	140	2.0k
Masafumi Uchida Japan	21	466 0.6×	445 0.7×	25 0.0×	29 0.1×	229 0.7×	126	1.6k
Georges Lawson Belgium	30	1.1k 1.5×	928 1.5×	21 0.0×	828 1.7×	366 1.1×	101	2.2k
Han Kim United States	22	307 0.4×	341 0.6×	17 0.0×	207 0.4×	218 0.7×	65	1.5k
Roy B. Sessions United States	28	441 0.6×	1.7k 2.9×	52 0.1×	1.2k 2.4×	947 2.8×	64	2.9k
John W. Werning United States	36	757 1.0×	2.3k 3.7×	65 0.1×	1.7k 3.4×	1.9k 5.8×	100	3.8k
O. Elbrønd Denmark	24	425 0.6×	962 1.6×	13 0.0×	1.1k 2.2×	408 1.2×	92	2.0k
Frans J. M. Hilgers Netherlands	46	3.3k 4.4×	2.0k 3.3×	75 0.1×	2.7k 5.5×	1.4k 4.1×	214	6.7k
Hans Edmund Eckel Germany	33	1.6k 2.2×	1.6k 2.7×	39 0.1×	1.8k 3.6×	911 2.7×	110	4.0k
Jonathan C. Irish Canada	23	218 0.3×	690 1.1×	14 0.0×	282 0.6×	279 0.8×	46	1.8k
Werner Kneist Germany	26	438 0.6×	1.8k 2.9×	12 0.0×	12 0.0×	786 2.3×	163	2.2k

Countries citing papers authored by Ken Yoshida

Since Specialization

Citations

This map shows the geographic impact of Ken Yoshida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken Yoshida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken Yoshida more than expected).

Fields of papers citing papers by Ken Yoshida

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ken Yoshida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken Yoshida. The network helps show where Ken Yoshida may publish in the future.

Co-authorship network of co-authors of Ken Yoshida

This figure shows the co-authorship network connecting the top 25 collaborators of Ken Yoshida. A scholar is included among the top collaborators of Ken Yoshida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ken Yoshida. Ken Yoshida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yamazaki, Hideya, Gen Suzuki, Koji Masui, et al.. (2024). The influence of Gleason score ≤ 6 histology on the outcome of high-risk localized prostate cancer after modern radiotherapy. Scientific Reports. 14(1). 8011–8011. 1 indexed citations

Yamazaki, Hideya, Gen Suzuki, Norihiro Aibe, et al.. (2024). Re-irradiation for isolated neck recurrence in head and neck tumor: impact of rN category. Scientific Reports. 14(1). 3107–3107. 1 indexed citations

Fukushima, Takuya, Jiro Nakano, Kazuki Fujii, et al.. (2024). Comparative Study on Associations Between Lung Cancer Prognosis and Diagnostic Criteria Set by the European Palliative Care Research Collaboration and the Asian Working Group for Cachexia. Thoracic Cancer. 16(2). e15503–e15503. 1 indexed citations

Ikushima, Hitoshi, Noriko Ii, Shin‐ei Noda, et al.. (2023). Patterns of care for brachytherapy in Japan. Journal of Radiation Research. 65(2). 168–176. 1 indexed citations

Yamazaki, Hideya, Gen Suzuki, Norihiro Aibe, et al.. (2023). Reirradiation for local recurrence of oral, pharyngeal, and laryngeal cancers: a multi-institutional study. Scientific Reports. 13(1). 3062–3062. 5 indexed citations

Takenaka, Tadashi, Hideya Yamazaki, Gen Suzuki, et al.. (2023). Initial tumor volume as an important predictor for indication of intra-cavitary brachytherapy, intra-cavitary/interstitial brachytherapy, and multi-catheter sole interstitial brachytherapy in cervical cancer patients treated with chemoradiotherapy. Journal of Contemporary Brachytherapy. 15(3). 191–197. 1 indexed citations

Murakami, Naoya, Koji Masui, Ken Yoshida, et al.. (2023). Hands-on seminar for image-guided adaptive brachytherapy and intracavitary/interstitial brachytherapy for uterine cervical cancer. Japanese Journal of Clinical Oncology. 53(6). 508–513. 5 indexed citations

Murakami, Naoya, Tairo Kashihara, Takahito Chiba, et al.. (2022). The combination of volumetric arc radiation therapy and boost high-dose rate interstitial brachytherapy for T3N2c tongue cancer: a technical report. Japanese Journal of Clinical Oncology. 53(1). 85–90.

Yamazaki, Hideya, Gen Suzuki, Koji Masui, et al.. (2022). Role of Brachytherapy Boost in Clinically Localized Intermediate and High-Risk Prostate Cancer: Lack of Benefit in Patients with Very High-Risk Factors T3b–4 and/or Gleason 9–10. Cancers. 14(12). 2976–2976. 2 indexed citations

10.

Yamazaki, Hideya, Gen Suzuki, Koji Masui, et al.. (2021). Novel Prognostic Index of High-Risk Prostate Cancer Using Simple Summation of Very High-Risk Factors. Cancers. 13(14). 3486–3486. 2 indexed citations

11.

Yamazaki, Hideya, Gen Suzuki, Norihiro Aibe, et al.. (2021). Reirradiation for Nasal Cavity or Paranasal Sinus Tumor—A Multi-Institutional Study. Cancers. 13(24). 6315–6315. 4 indexed citations

12.

Yamazaki, Hideya, Gen Suzuki, Koji Masui, et al.. (2021). Radiotherapy for Clinically Localized T3b or T4 Very-High-Risk Prostate Cancer-Role of Dose Escalation Using High-Dose-Rate Brachytherapy Boost or High Dose Intensity Modulated Radiotherapy. Cancers. 13(8). 1856–1856. 7 indexed citations

13.

Yamazaki, Hideya, Gen Suzuki, Norihiro Aibe, et al.. (2021). Ultrahypofractionated Radiotherapy versus Conventional to Moderate Hypofractionated Radiotherapy for Clinically Localized Prostate Cancer. Cancers. 14(1). 195–195.

14.

Yamazaki, Hideya, Koji Masui, Gen Suzuki, et al.. (2020). Potential Risk of Other-Cause Mortality Due to Long-Term Androgen Deprivation Therapy in Elderly Patients with Clinically Localized Prostate Cancer Treated with Radiotherapy—A Confirmation Study. Journal of Clinical Medicine. 9(7). 2296–2296. 5 indexed citations

15.

Yamazaki, Hideya, Koji Masui, Gen Suzuki, et al.. (2019). Effect of Androgen Deprivation Therapy on Other-Cause of Mortality in Elderly Patients with Clinically Localized Prostate Cancer Treated with Modern Radiotherapy: Is There a Negative Impact?. Journal of Clinical Medicine. 8(3). 338–338. 8 indexed citations

16.

Kashihara, Tairo, Naoya Murakami, Nikolaos Tselis, et al.. (2019). Hyaluronate gel injection for rectum dose reduction in gynecologic high-dose-rate brachytherapy: initial Japanese experience. Journal of Radiation Research. 60(4). 501–508. 31 indexed citations

17.

Yamazaki, Hideya, Koji Masui, Gen Suzuki, et al.. (2018). High-dose-rate brachytherapy monotherapy versus low-dose-rate brachytherapy with or without external beam radiotherapy for clinically localized prostate cancer. Radiotherapy and Oncology. 132. 162–170. 23 indexed citations

18.

Yamazaki, Hideya, Koji Masui, Gen Suzuki, et al.. (2018). Radiotherapy for Elderly Patients Aged ≥75 Years with Clinically Localized Prostate Cancer—Is There a Role of Brachytherapy?. Journal of Clinical Medicine. 7(11). 424–424. 10 indexed citations

19.

Yamazaki, Hideya, Koji Masui, Gen Suzuki, et al.. (2018). High-Dose-Rate Brachytherapy Monotherapy versus Image-Guided Intensity-Modulated Radiotherapy with Helical Tomotherapy for Patients with Localized Prostate Cancer. Cancers. 10(9). 322–322. 5 indexed citations

20.

Yamazaki, Hideya, Satoaki Nakamura, Gen Suzuki, et al.. (2005). Hypofractionated Radiotherapy for Localized Prostate Cancer: A Challenging Accelerated Hypofractionated Radiotherapy.. Anticancer Research. 35(10). 5167–77. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact